Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacogenetic individualization of opioid analgesic therapy
2010-020428-23Phase 4Active
- Sponsor
- AnaMar
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of morphine in pain (2 arms), sponsored by AnaMar. Primary endpoints: Analgesic efficacy by visual analog scale and Change in pain intensity from baseline. Started Jun 2010; status: active.
02
Drugs
morphine
03
Conditions
pain
Beyond the preview
Go deeper on 2010-020428-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020428-23.